Anagallis Arvensis
ANAGALLIS ARVENSIS
ORAL
HUMAN OTC DRUG
Anagallis Arvensis is an FDA drug label for the active ingredient ANAGALLIS ARVENSIS manufactured by Hahnemann Laboratories, INC. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20230802.
- Generic name
- ANAGALLIS ARVENSIS
- Manufacturer
- Hahnemann Laboratories, INC.
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 37662-3664
- Application
- N/A
- Label effective
- 20230802
Active ingredients
Indications & Usage
Not available.
Dosage & Administration
Not available.
Contraindications
Not available.
Warnings
Not available.
Adverse Reactions
Not available.